celastrol has been researched along with paclitaxel in 10 studies
| Studies (celastrol) | Trials (celastrol) | Recent Studies (post-2010) (celastrol) | Studies (paclitaxel) | Trials (paclitaxel) | Recent Studies (post-2010) (paclitaxel) |
|---|---|---|---|---|---|
| 885 | 1 | 741 | 31,874 | 5,729 | 15,395 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 9 (90.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bastow, KF; Chang, FR; Chen, IH; Cragg, GM; Hayashi, K; Lee, KH; Liaw, CC; Nakanishi, Y; Nozaki, H; Wu, YC | 1 |
| Han, AR; Kang, GY; Lee, D; Lee, YS; Nam, JW; Seo, EK | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
| Ding, F; Ding, J; Li, N; Li, X; Liu, R; Liu, W; Ning, Y; Ren, S; Wang, H; Zheng, H | 1 |
| An, S; Byun, JY; Chung, HY; Eum, DY; Kim, MJ; Lee, JH; Lee, SJ; Park, KH; Seo, WD; Suh, Y; Yoon, CH | 1 |
| Chai, Y; Fan, G; Hu, Y; Liu, H; Qi, Y | 1 |
| Jeoung, D; Kim, H; Kim, Y | 1 |
| Choi, MG; Ihm, SH; Kang, JG; Kim, CS; Kim, SH; Lee, SJ; Yoo, HJ | 1 |
| Cha, EY; Lee, JS; Lee, MS; Lee, Y; Na, J; Park, JB; Sul, JY | 1 |
10 other study(ies) available for celastrol and paclitaxel
| Article | Year |
|---|---|
Antitumor agents. 228. five new agarofurans, Reissantins A-E, and cytotoxic principles from Reissantia buchananii.
Topics: Alkaloids; Antineoplastic Agents, Phytogenic; Celastraceae; Drug Screening Assays, Antitumor; Female; Humans; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Ovarian Neoplasms; Plants, Medicinal; Sesquiterpenes; Tanzania; Tumor Cells, Cultured | 2003 |
Diarylheptanoids from the seeds of Alpinia katsumadai as heat shock factor 1 inducers.
Topics: Alpinia; Diarylheptanoids; DNA-Binding Proteins; Heat Shock Transcription Factors; HSP70 Heat-Shock Proteins; Molecular Structure; Republic of Korea; Seeds; Transcription Factors | 2011 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |
Synthesis and biological evaluation of celastrol derivatives as anti-ovarian cancer stem cell agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Movement; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Molecular Structure; Neoplastic Stem Cells; Ovarian Neoplasms; Pentacyclic Triterpenes; Structure-Activity Relationship; Triterpenes; Wound Healing | 2019 |
Triterpenoid pristimerin synergizes with taxol to induce cervical cancer cell death through reactive oxygen species-mediated mitochondrial dysfunction.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; bcl-2-Associated X Protein; Cell Death; Drug Synergism; Female; HeLa Cells; Humans; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; Paclitaxel; Pentacyclic Triterpenes; Reactive Oxygen Species; Receptors, TNF-Related Apoptosis-Inducing Ligand; Triterpenes; Up-Regulation; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2011 |
Effects of celastrol on human cervical cancer cells as revealed by ion-trap gas chromatography-mass spectrometry based metabolic profiling.
Topics: Analysis of Variance; Annexin A5; Antineoplastic Agents, Phytogenic; Caspase 3; Cell Proliferation; Cell Survival; Cisplatin; Doxorubicin; Enzyme Activation; Female; Gas Chromatography-Mass Spectrometry; HeLa Cells; Humans; Membrane Potential, Mitochondrial; Metabolome; Paclitaxel; Pentacyclic Triterpenes; Triterpenes; Uterine Cervical Neoplasms | 2013 |
Tubulin Beta3 Serves as a Target of HDAC3 and Mediates Resistance to Microtubule-Targeting Drugs.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression; Histone Deacetylase 6; Histone Deacetylases; Humans; Microtubules; Paclitaxel; Pentacyclic Triterpenes; Promoter Regions, Genetic; Triterpenes; Tubulin | 2015 |
Cytotoxic effect of celastrol alone or in combination with paclitaxel on anaplastic thyroid carcinoma cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Endoplasmic Reticulum Stress; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Proteins; NF-kappa B; Oncogene Protein v-akt; Paclitaxel; Pentacyclic Triterpenes; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Thyroid Carcinoma, Anaplastic; Triterpenes | 2017 |
Combination of pristimerin and paclitaxel additively induces autophagy in human breast cancer cells via ERK1/2 regulation.
Topics: Apoptosis; Autophagy; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Drug Synergism; Female; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Paclitaxel; Pentacyclic Triterpenes; Triterpenes | 2018 |